High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome

A. Ravasio, M. Pasquinelli, B. Currò Dossi, W. Neri, C. Guidi, M. Gessaroli, F. Rasi, R. Fabbri, G. Mazzini, GG Rebucci, G. Padoan, C. Callegarini, G. Ciucci, AR Guidi, G. Facchini, M. Galeotti, M. Casmiro, G. Bianchedi, [No Value] Tola, V. GovoniE. Granieri, G. Tralli, V. Tugnoli, V. Mussuto, R. D'Alessandro, M. Guarino, R. Baldrati, S. Laudadio, T. Sacquegna, F. Salvi, G. Ambrosetto, P. Sorgato, V. Ferrari, M. Gentilini, A. Colombo, E. Merelli, V. Miele, V. Lolli, M. Santangelo, L. Motti, D. Guidetti, F. Solimè, F. Granella, G. Pavesi, I. Allegri, L. Falco, A. Scaglioni, E. Montanari, S. Cammarata, V. Poli

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We report the effects of treatment with plasma-exchange (PE) and intravenous immune globulins (IVIg) in 36 out of 50 patients with Guillain-Barré syndrome (GBS) recruited by an incidence study in the Emilia-Romagna region of Italy. Comparison of the patients treated with PE and IVIg showed no significant differences in terms of effectiveness in improving the clinical course of GBS: at one month, respectively 11.1% and 25% had recovered, and 55.5% and 58.3% had improved by at least one grade. These results are in agreement with those of the Dutch GBS trial. No relapses were observed in either group. Moreover, our results showed no difference in clinical outcome at 1 and 3 months between the patients receiving only one therapy and those receiving two; a second cycle of therapy did not seem to improve the clinical course of the disease significantly. We conclude that PE and IVIg are both safe and effective therapies for GBS.

Original languageEnglish
Pages (from-to)487-492
Number of pages6
JournalItalian Journal of Neurological Sciences
Volume16
Issue number6
DOIs
Publication statusPublished - Sep 1995

Fingerprint

Plasma Exchange
Intravenous Immunoglobulins
Therapeutics
Italy
Cohort Studies
Recurrence

Keywords

  • Guillain-Barré Syndrome
  • Immune globulins
  • Plasma-exchange therapy

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

Ravasio, A., Pasquinelli, M., Dossi, B. C., Neri, W., Guidi, C., Gessaroli, M., ... Poli, V. (1995). High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome. Italian Journal of Neurological Sciences, 16(6), 487-492. https://doi.org/10.1007/BF02229327

High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome. / Ravasio, A.; Pasquinelli, M.; Dossi, B. Currò; Neri, W.; Guidi, C.; Gessaroli, M.; Rasi, F.; Fabbri, R.; Mazzini, G.; Rebucci, GG; Padoan, G.; Callegarini, C.; Ciucci, G.; Guidi, AR; Facchini, G.; Galeotti, M.; Casmiro, M.; Bianchedi, G.; Tola, [No Value]; Govoni, V.; Granieri, E.; Tralli, G.; Tugnoli, V.; Mussuto, V.; D'Alessandro, R.; Guarino, M.; Baldrati, R.; Laudadio, S.; Sacquegna, T.; Salvi, F.; Ambrosetto, G.; Sorgato, P.; Ferrari, V.; Gentilini, M.; Colombo, A.; Merelli, E.; Miele, V.; Lolli, V.; Santangelo, M.; Motti, L.; Guidetti, D.; Solimè, F.; Granella, F.; Pavesi, G.; Allegri, I.; Falco, L.; Scaglioni, A.; Montanari, E.; Cammarata, S.; Poli, V.

In: Italian Journal of Neurological Sciences, Vol. 16, No. 6, 09.1995, p. 487-492.

Research output: Contribution to journalArticle

Ravasio, A, Pasquinelli, M, Dossi, BC, Neri, W, Guidi, C, Gessaroli, M, Rasi, F, Fabbri, R, Mazzini, G, Rebucci, GG, Padoan, G, Callegarini, C, Ciucci, G, Guidi, AR, Facchini, G, Galeotti, M, Casmiro, M, Bianchedi, G, Tola, NV, Govoni, V, Granieri, E, Tralli, G, Tugnoli, V, Mussuto, V, D'Alessandro, R, Guarino, M, Baldrati, R, Laudadio, S, Sacquegna, T, Salvi, F, Ambrosetto, G, Sorgato, P, Ferrari, V, Gentilini, M, Colombo, A, Merelli, E, Miele, V, Lolli, V, Santangelo, M, Motti, L, Guidetti, D, Solimè, F, Granella, F, Pavesi, G, Allegri, I, Falco, L, Scaglioni, A, Montanari, E, Cammarata, S & Poli, V 1995, 'High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome', Italian Journal of Neurological Sciences, vol. 16, no. 6, pp. 487-492. https://doi.org/10.1007/BF02229327
Ravasio, A. ; Pasquinelli, M. ; Dossi, B. Currò ; Neri, W. ; Guidi, C. ; Gessaroli, M. ; Rasi, F. ; Fabbri, R. ; Mazzini, G. ; Rebucci, GG ; Padoan, G. ; Callegarini, C. ; Ciucci, G. ; Guidi, AR ; Facchini, G. ; Galeotti, M. ; Casmiro, M. ; Bianchedi, G. ; Tola, [No Value] ; Govoni, V. ; Granieri, E. ; Tralli, G. ; Tugnoli, V. ; Mussuto, V. ; D'Alessandro, R. ; Guarino, M. ; Baldrati, R. ; Laudadio, S. ; Sacquegna, T. ; Salvi, F. ; Ambrosetto, G. ; Sorgato, P. ; Ferrari, V. ; Gentilini, M. ; Colombo, A. ; Merelli, E. ; Miele, V. ; Lolli, V. ; Santangelo, M. ; Motti, L. ; Guidetti, D. ; Solimè, F. ; Granella, F. ; Pavesi, G. ; Allegri, I. ; Falco, L. ; Scaglioni, A. ; Montanari, E. ; Cammarata, S. ; Poli, V. / High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome. In: Italian Journal of Neurological Sciences. 1995 ; Vol. 16, No. 6. pp. 487-492.
@article{0a47bf2ba0324b78a0121a63156290ae,
title = "High dose intravenous immune globulins and plasma exchange in Guillain-Barr{\'e} Syndrome",
abstract = "We report the effects of treatment with plasma-exchange (PE) and intravenous immune globulins (IVIg) in 36 out of 50 patients with Guillain-Barr{\'e} syndrome (GBS) recruited by an incidence study in the Emilia-Romagna region of Italy. Comparison of the patients treated with PE and IVIg showed no significant differences in terms of effectiveness in improving the clinical course of GBS: at one month, respectively 11.1{\%} and 25{\%} had recovered, and 55.5{\%} and 58.3{\%} had improved by at least one grade. These results are in agreement with those of the Dutch GBS trial. No relapses were observed in either group. Moreover, our results showed no difference in clinical outcome at 1 and 3 months between the patients receiving only one therapy and those receiving two; a second cycle of therapy did not seem to improve the clinical course of the disease significantly. We conclude that PE and IVIg are both safe and effective therapies for GBS.",
keywords = "Guillain-Barr{\'e} Syndrome, Immune globulins, Plasma-exchange therapy",
author = "A. Ravasio and M. Pasquinelli and Dossi, {B. Curr{\`o}} and W. Neri and C. Guidi and M. Gessaroli and F. Rasi and R. Fabbri and G. Mazzini and GG Rebucci and G. Padoan and C. Callegarini and G. Ciucci and AR Guidi and G. Facchini and M. Galeotti and M. Casmiro and G. Bianchedi and Tola, {[No Value]} and V. Govoni and E. Granieri and G. Tralli and V. Tugnoli and V. Mussuto and R. D'Alessandro and M. Guarino and R. Baldrati and S. Laudadio and T. Sacquegna and F. Salvi and G. Ambrosetto and P. Sorgato and V. Ferrari and M. Gentilini and A. Colombo and E. Merelli and V. Miele and V. Lolli and M. Santangelo and L. Motti and D. Guidetti and F. Solim{\`e} and F. Granella and G. Pavesi and I. Allegri and L. Falco and A. Scaglioni and E. Montanari and S. Cammarata and V. Poli",
year = "1995",
month = "9",
doi = "10.1007/BF02229327",
language = "English",
volume = "16",
pages = "487--492",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome

AU - Ravasio, A.

AU - Pasquinelli, M.

AU - Dossi, B. Currò

AU - Neri, W.

AU - Guidi, C.

AU - Gessaroli, M.

AU - Rasi, F.

AU - Fabbri, R.

AU - Mazzini, G.

AU - Rebucci, GG

AU - Padoan, G.

AU - Callegarini, C.

AU - Ciucci, G.

AU - Guidi, AR

AU - Facchini, G.

AU - Galeotti, M.

AU - Casmiro, M.

AU - Bianchedi, G.

AU - Tola, [No Value]

AU - Govoni, V.

AU - Granieri, E.

AU - Tralli, G.

AU - Tugnoli, V.

AU - Mussuto, V.

AU - D'Alessandro, R.

AU - Guarino, M.

AU - Baldrati, R.

AU - Laudadio, S.

AU - Sacquegna, T.

AU - Salvi, F.

AU - Ambrosetto, G.

AU - Sorgato, P.

AU - Ferrari, V.

AU - Gentilini, M.

AU - Colombo, A.

AU - Merelli, E.

AU - Miele, V.

AU - Lolli, V.

AU - Santangelo, M.

AU - Motti, L.

AU - Guidetti, D.

AU - Solimè, F.

AU - Granella, F.

AU - Pavesi, G.

AU - Allegri, I.

AU - Falco, L.

AU - Scaglioni, A.

AU - Montanari, E.

AU - Cammarata, S.

AU - Poli, V.

PY - 1995/9

Y1 - 1995/9

N2 - We report the effects of treatment with plasma-exchange (PE) and intravenous immune globulins (IVIg) in 36 out of 50 patients with Guillain-Barré syndrome (GBS) recruited by an incidence study in the Emilia-Romagna region of Italy. Comparison of the patients treated with PE and IVIg showed no significant differences in terms of effectiveness in improving the clinical course of GBS: at one month, respectively 11.1% and 25% had recovered, and 55.5% and 58.3% had improved by at least one grade. These results are in agreement with those of the Dutch GBS trial. No relapses were observed in either group. Moreover, our results showed no difference in clinical outcome at 1 and 3 months between the patients receiving only one therapy and those receiving two; a second cycle of therapy did not seem to improve the clinical course of the disease significantly. We conclude that PE and IVIg are both safe and effective therapies for GBS.

AB - We report the effects of treatment with plasma-exchange (PE) and intravenous immune globulins (IVIg) in 36 out of 50 patients with Guillain-Barré syndrome (GBS) recruited by an incidence study in the Emilia-Romagna region of Italy. Comparison of the patients treated with PE and IVIg showed no significant differences in terms of effectiveness in improving the clinical course of GBS: at one month, respectively 11.1% and 25% had recovered, and 55.5% and 58.3% had improved by at least one grade. These results are in agreement with those of the Dutch GBS trial. No relapses were observed in either group. Moreover, our results showed no difference in clinical outcome at 1 and 3 months between the patients receiving only one therapy and those receiving two; a second cycle of therapy did not seem to improve the clinical course of the disease significantly. We conclude that PE and IVIg are both safe and effective therapies for GBS.

KW - Guillain-Barré Syndrome

KW - Immune globulins

KW - Plasma-exchange therapy

UR - http://www.scopus.com/inward/record.url?scp=0028865938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028865938&partnerID=8YFLogxK

U2 - 10.1007/BF02229327

DO - 10.1007/BF02229327

M3 - Article

C2 - 8749707

AN - SCOPUS:0028865938

VL - 16

SP - 487

EP - 492

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 6

ER -